Skip to main content
BioMedli
BioMedli
BiomarkersProtocolsBlogPricing
Log in
Biomarkers / Non-HDL Cholesterol-to-Apolipoprotein B Ratio (Non-HDL-C/ApoB)
Core coverageDerived marker

Non-HDL Cholesterol-to-Apolipoprotein B Ratio (Non-HDL-C/ApoB)

Non-HDL Cholesterol-to-Apolipoprotein B Ratio (Non-HDL-C/ApoB) is a calculated lab index that combines same-date measurements to provide additional context alongside the source results.

BioMedli support

Extracted or calculated with provenance

On this page

OverviewClinical ImportanceResult InterpretationTesting GuideTechnical Details

What is Non-HDL Cholesterol-to-Apolipoprotein B Ratio (Non-HDL-C/ApoB)?

The Non-HDL Cholesterol-to-Apolipoprotein B Ratio (Non-HDL-C/ApoB) is a calculated value that provides a more comprehensive picture of cardiovascular risk than traditional cholesterol measurements alone.

Understanding cholesterol's 'bad' players

Cholesterol itself is essential for building healthy cells. However, it needs to be transported in the blood by particles called lipoproteins. "Bad" cholesterol, or low-density lipoprotein (LDL), and other non-high-density lipoprotein (non-HDL) particles are primarily responsible for delivering cholesterol to the body's tissues. When these particles are elevated or too numerous, they can contribute to the buildup of plaque in the arteries.

Apolipoprotein B: the count of "bad" particles

Apolipoprotein B (ApoB) is a protein that is a major component of LDL and other atherogenic (plaque-forming) lipoproteins. Measuring ApoB provides a direct count of these potentially harmful particles. Non-HDL cholesterol (Non-HDL-C) is calculated by subtracting HDL cholesterol (the "good" cholesterol) from the total cholesterol. It effectively captures the cholesterol carried by all the "bad" particles.

The ratio for refined risk assessment

The Non-HDL-C/ApoB ratio combines the total cholesterol carried by atherogenic particles (Non-HDL-C) with the actual number of those particles (ApoB). A higher ratio suggests that each individual particle is carrying more cholesterol, which may indicate a more atherogenic particle profile and potentially a higher risk for cardiovascular events.

Why is Non-HDL Cholesterol-to-Apolipoprotein B Ratio (Non-HDL-C/ApoB) important?

The Non-HDL Cholesterol-to-Apolipoprotein B Ratio (Non-HDL-C/ApoB) is a powerful indicator of cardiovascular risk. It offers a refined assessment by considering not just the total amount of "bad" cholesterol, but also the underlying number and composition of the particles that carry it. This ratio helps to identify individuals who may have a higher risk of plaque buildup in their arteries, even if their standard LDL cholesterol levels appear to be within a seemingly normal range.

When levels drop too low

When the Non-HDL-C/ApoB ratio is appropriately low, it indicates a reduced presence of atherogenic lipoproteins. This signifies a lower likelihood of plaque formation and progression in the arteries, contributing to better long-term cardiovascular health and resilience. It suggests that the cholesterol being transported is primarily within less harmful particles, and the overall cholesterol burden in the bloodstream is well-managed.

When levels climb too high

A high Non-HDL-C/ApoB ratio suggests that the atherogenic particles in the blood are either too numerous or are carrying a disproportionately high amount of cholesterol. This scenario significantly increases the risk of developing atherosclerosis – the hardening and narrowing of arteries due to plaque buildup. Over time, this can lead to serious cardiovascular events such as heart attacks and strokes. It highlights a need for targeted lifestyle modifications and potentially medical intervention.

The long view on Non-HDL-C/ApoB ratio

Maintaining an optimal Non-HDL-C/ApoB ratio is crucial for long-term cardiovascular resilience. It is a marker that reflects the effectiveness of metabolic health and dietary strategies in managing cholesterol. Consistently high ratios over time are associated with an elevated cumulative risk for cardiovascular disease, emphasizing the importance of proactive management and regular monitoring to protect vascular health.

What do my Non-HDL Cholesterol-to-Apolipoprotein B Ratio (Non-HDL-C/ApoB) results mean?

Low Non-HDL-C/ApoB ratio

A low ratio generally indicates a favorable lipid profile, with fewer atherogenic particles and less cholesterol being carried by them. This is associated with a lower risk of cardiovascular disease and is often achieved through healthy lifestyle choices, including a balanced diet low in saturated and trans fats, regular exercise, and maintaining a healthy weight.

Optimal Non-HDL-C/ApoB ratio

While specific optimal ranges can vary based on individual risk factors and clinical guidelines, a low ratio is consistently associated with better cardiovascular outcomes. This typically means that your non-HDL cholesterol is well-controlled relative to the number of atherogenic particles. Your healthcare provider will interpret this ratio in the context of your overall health profile.

High Non-HDL-C/ApoB ratio

A high ratio is a red flag for increased cardiovascular risk. It suggests that even if LDL cholesterol seems borderline, the nature of the cholesterol-carrying particles may be more harmful. This can be influenced by genetics, diet, metabolic syndrome, diabetes, and other conditions. A persistently high ratio warrants investigation and a discussion with your healthcare provider about management strategies.

Factors that influence Non-HDL-C/ApoB results

Several factors can influence this ratio. Diet, particularly the intake of saturated and trans fats, refined carbohydrates, and sugars, plays a significant role. Lifestyle factors such as physical activity, smoking, and alcohol consumption are also impactful. Medical conditions like diabetes, insulin resistance, metabolic syndrome, and thyroid disorders can affect lipid metabolism. Furthermore, age and genetics can pre-dispose individuals to certain lipid profiles. Pregnancy can also lead to temporary changes in lipid levels.

Do I need a Non-HDL Cholesterol-to-Apolipoprotein B Ratio (Non-HDL-C/ApoB) test?

Are you concerned about your heart health, or have you been told you have elevated cholesterol? Are you looking for a more precise understanding of your cardiovascular risk beyond standard cholesterol tests?

The Non-HDL Cholesterol-to-Apolipoprotein B Ratio (Non-HDL-C/ApoB) is a derived measure that provides a deeper insight into your cardiovascular risk. It goes beyond simply measuring total cholesterol or LDL by assessing the number and cholesterol-carrying capacity of the "bad" cholesterol particles, offering a more refined picture of potential plaque-forming activity in your arteries.

Testing your Non-HDL-C/ApoB ratio empowers you with personalized data. Understanding this ratio can help your healthcare provider tailor interventions, whether it involves specific dietary changes, exercise regimens, or targeted medical treatments, to effectively manage your cardiovascular health and build long-term resilience.

Technical & PDF Reading Details

Measurement context

BioMedli calculates this only when all required source measurements are present on the same test date and their units can be normalized safely. Formula: non-HDL cholesterol / apolipoprotein B.

How PDF reading works

Read directly when printed. Otherwise calculate from valid same-date source values and retain calculation provenance.

Calculation

non-HDL cholesterol / apolipoprotein B

Required same-date inputs

  • Non-HDL Cholesterol
  • Apolipoprotein B

Educational context only

BioMedli organizes laboratory information and trends. It does not diagnose disease, define a personal target, or replace a qualified healthcare professional.

Related biomarkers

High-sensitivity CRPAspartate Aminotransferase (AST)Carbon Dioxide, TotalApolipoprotein BAtherogenic CoefficientAtherogenic Index of Plasma
Upload a report
Illustrated BioMedli health journey with lab reports, mountains, flowers, and people exploring health data

Private health intelligence

Make every lab report part of the story.

BioMedli turns scattered PDF lab reports into a private, searchable health timeline built for trends, protocols, and better questions at your next appointment.

Read yourselfExplore sample dashboard
BioMedli
BioMedli

A privacy-first lab report timeline for people who want to understand what changed, what matters, and what to retest next.

PDF parsingBiomarker trendsPrivate by default
BioMedli - Your longitudinal health intelligence layer | Product Hunt

Product

  • How It Works
  • Features
  • Biomarkers
  • Protocols
  • Pricing
  • Changelog

Learn

  • About
  • Upload Guide
  • Blog
  • Help Center
  • Safety
  • Contact

Legal

  • Privacy
  • Terms
  • Conditions
  • Cookie Policy
  • Refund Policy

© 2026 Terramedici LifeSciences LLP. All rights reserved.

BioMedli is an educational tool, not a diagnostic device, medical provider, or emergency service. Always consult with a qualified healthcare professional for clinical decisions.